Arthritis Research Canada will be hosting its annual ARThritis Soirée on Thursday, May 26 at 7pm. The Soirée will take place at the Vancouver Club, located at 915 W. Hastings Street, Vancouver. This gala will raise money for arthritis research, awareness, and advocacy. The concept behind the gala is that research has shown that art adds to one’s well-being. For many, it is a key element of managing chronic pain. Each year, the Soirée features one form of art. This year’s feature is the Art of Fencing with Olympic and World Champions.
The ARThritis Soirée is an evening designed to attract the city’s most prominent business and community leaders, philanthropists, doctors, scientists, healthcare professionals, and donors through an appreciation of art and a desire to support arthritis research.
The evening’s event will be emceed by Fred Lee, CBC, Vancouver Courier and The Province’s Man About Town. Guests can enjoy hors d’oeuvres, champagne, premium spirits and exquisite BC wines from LaStella and Le Vieux Pin wineries and indulge in legendary Joe Fortes oysters and Northern Divine Caviar.
There will be a live and silent auction, with items such as a chef’s table experience at Joe Fortes, photo sessions, paintings, and entertainment, vacation, spa and lifestyle packages. Buy your raffle ticket for a chance to win a beautiful Birk’s diamond necklace. Please note guests will have complimentary valet parking. Tickets to The 2016 ARThritis Soirée is available for $245.00 and includes complementary valet parking and a partial tax receipt. To learn more about the event, please click here.
(Please click on the map for more information about the provincial drug formulary updates.)
The latest provincial listings, at your fingertips
Good news for people living with autoimmune arthritis in Canada!
Arthritis Consumer Experts (ACE) maps out the latest news for you: Read about the important changes to provincial drug formularies and what it means for Canadians living with autoimmune arthritis. The changes covered in this update affect people living with rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and juvenile idiopathic arthritis (JIA). Continue reading →
A study in the Swedish Malmo Preventive Medicine Program (MPMP) found that men with low testosterone were more likely to develop rheumatoid arthritis. The study participants included 33,000 people born between 1921 and 1949. As part of the study, the participants underwent a number of tests, filled out questionnaires, and provided blood samples.
In the study, low testosterone levels are observed in both men and women with rheumatoid arthritis (RA). Further study is required to determine whether low testosterone levels are to blame for the onset of RA, or it is RA that drops the levels of testosterone. Continue reading →
Arthritis Consumer Experts (ACE) is asking for your valuable feedback on new BC PharmaCare policy.
Arthritis Consumer Experts (ACE) is asking for your valuable feedback on new BC PharmaCare policy. Gathering your views is very important to the advocacy work that we do on your behalf.
This survey includes 13 questions for people living with arthritis and will take approximately 10 minutes to complete. Your participation will be anonymous and the results will be pooled for analysis to assure your complete privacy. Your responses will in no way impact on your health care or public health insurance coverage.
Thank you for taking the time to participate in this important survey. Your feedback helps us to improve the quality and relevance of Arthritis Consumer Experts’ work.
A team of researchers has developed Canada’s first set of systematic measures for tracking how well or poorly health systems are doing in providing services to people who have inflammatory arthritis (IA), a potentially crippling disease that is on the rise in Canada.
The researchers developed six key measures for gauging access to specialist care and initiation of treatment for people with IA, a disease grouping that includes rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, and psoriatic arthritis. The work is described in March issue of The Journal of Rheumatology.
People who receive early diagnosis and start of treatment have a better chance of responding well and avoiding permanent joint damage from rheumatoid arthritis (RA), the most common form of IA. There is a growing body of evidence that early detection and treatment are also crucial to good outcomes for people who have other types of IA. Continue reading →
Arthritis in Saskatchewan – Surveying Saskatchewan electoral candidates
Do you have a burning question you would like to ask?
Arthritis Consumer Experts (ACE) asks Saskatchewan’s political leaders to share their plan on how to improve arthritis prevention, treatment and care.
Arthritis has devastating and debilitating effects on the lives of more than 150,000 Saskatchewan residents aged 15 years and above. Arthritis is the leading cause of disability and work disability in Saskatchewan. About a quarter of the population with arthritis between 20 and 54 years of age in Saskatchewan were not in the labour force because of their arthritis, costing Saskatchewan’s economy more than $640 million in productivity losses.